Appointments

866.320.4573

Request an Appointment

Questions

800.223.2273

Contact us with Questions

Expand Content

Howard Goldman, MD

216.444.5600

Howard Goldman, MD
Department: Urology
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.5121
WorkFax:216.445.2267
Howard Goldman, MD
Department: Urology
Location: Hillcrest Hospital
Mail Code HC22
6770 Mayfield Road
Mayfield Heights, OH 44124
WorkAppointment:216.444.5600
DeskDesk:440.461.8989
WorkFax:216.445.2267
Howard Goldman, MD
Department: Urology
Location: Twinsburg Family Health & Surgery Center
Mail Code TWL1
8701 Darrow Road
Twinsburg, OH 44087
WorkAppointment:216.444.5600
DeskDesk:330.888.4000
WorkFax:216.445.2267
Howard Goldman, MD
Department: Obstetrics and Gynecology
Location: Cleveland Clinic Main Campus
Mail Code Q10-1
9500 Euclid Avenue
Cleveland, OH 44195
WorkAppointment:216.444.5600
DeskDesk:216.445.5121
WorkFax:216.445.2267
Surgeon:
Yes
Treats:
Adults Only

Biographical Sketch

Dr. Howard B. Goldman is fellowship trained and board certified in the subspecialty of female pelvic medicine and reconstructive surgery. He is a Professor on the faculty of the Cleveland Clinic Lerner College of Medicine. He is also an expert on quality and patient safety and is the Institute Vice Chairman for Quality at the Glickman Urologic Institute and a member of the AUA QPSI committee. He has a joint appointment in the departments of urology and obstetrics and gynecology, is actively involved in the training of fellows and residents and is the past Fellowship director for Female Pelvic Medicine and Reconstructive Surgery in the Department of Urology at the Cleveland Clinic. His interests are in the medical and surgical treatment of urinary incontinence and other types of voiding dysfunction, prolapse repair, complex redo female urologic surgery and fistula repair. He has authored over 150 articles and book chapters, is the editor of three textbooks, has been a visiting professor in the United States and abroad and given numerous invited lectures. He is on the editorial board of a number of journals and is currently an Assistant Editor of the Journal of Urology. He has served on a number of guidelines and best practice statement panels for the AUA and international organizations. He has also been involved in the development of innovative techniques for the treatment of urinary incontinence and prolapse and received a number of awards for his work.

Professional Highlights

  • Co-Editor of textbook, "Female Urology - A Practical Clinical Guide"

Education & Fellowships

Fellowship - Cleveland Clinic
Female Urology and Voiding Dysfunction
Cleveland, OH USA
1998
Residency - University of Tennessee Health Sciences Center
Urology
Memphis, TN USA
1997
Residency - University of Tennessee Health Sciences Center
Surgery
Memphis, TN USA
1993
Internship - University of Tennessee Health Sciences Center
Surgery
Memphis, TN USA
1992
Medical School - Albert Einstein College of Medicine
New York, NY USA
1991
Undergraduate - University of California-Los Angeles
Los Angeles, CA USA
1987

Certifications

  • Urology
  • Urology- Female Pelvic Medicine & Reconstructive Surgery

Specialty Interests

female urology, incontinence, pelvic floor reconstruction, prolapse surgery, voiding dysfunction, Incontinence, repair of complications of pelvic floor surgery

Innovations & Patents

Involved in development of innovative new techniques of neuromodulation for the treatment of overactive bladder problems

Memberships

  • American Urological Association
  • International Urogynecological Association
  • Society for Female Urology and Urodynamics
  • International Continence Society
  • American Urogynecologic Society
  • International Urogynecologic Association

Treatment & Services

Specialty in Diseases and Conditions

Industry Relationships

Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.

To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. The Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists receive or have the right to receive royalties or (iv) its physicians/ scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, the Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.

As of 11/27/2013, Dr. Goldman has reported the financial relationships with the companies listed below. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by the Cleveland Clinic. To learn more about the Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.

Consulting and/or Speaking. Dr. Goldman receives fees of $5,000 or more per year as a paid consultant, speaker or member of an advisory committee for the following companies:

  • Allergan, Inc
  • Astellas Pharma US, Inc.

Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias.

* Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.

Languages Spoken

  • English